Skip to main content

GoodRx Holdings, Inc NT 10-Q, filed Nov 10, 2026

GoodRx Holdings, Inc. (GDRX)

GoodRx Holdings, Inc. said certain financial statements should no longer be relied upon after revenue recognition errors undercounted Pharma Direct revenue. It delayed its quarter ended September 30, 2026 filing and expects one or more material weaknesses in internal controls. AI summary

NT 10-Q 2026-11-10 For: 2026-09-30
View Original
Added on November 10, 2026